Dyne Therapeutics, Inc.
Develops targeted therapies for genetically driven neuromuscular diseases.
DYN | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1560 TRAPELO ROAD, 2451 WALTHAM
- Website:
- https://dyne-tx.com/
- Sector:
- Manufacturing
Description
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies for individuals with genetically driven neuromuscular diseases. The company utilizes its proprietary FORCE™ platform, which is engineered to enable the targeted delivery of therapeutics to muscle tissue and address the root cause of disease. Dyne's clinical pipeline includes investigational treatments for myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral muscular dystrophy (FSHD). The company's primary objective is to deliver therapies that provide significant functional improvement for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Dyne Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Dyne Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Dyne Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
